Multiple factors contribute to COVID-19 vaccine hesitancy among older, ethnic minorities
By
Amy Novotney
Nov 08, 2021
While older adults from minority ethnic backgrounds are at increased risk of contracting and dying from COVID-19, vaccine hesitancy continues to be high among these individuals. In an effort to better...
Protection declines dramatically over time for all three COVID-19 vaccines: study
By
Amy Novotney
Nov 08, 2021
As the delta variant became the dominant strain of coronavirus across the United States, all three COVID-19 vaccines available to Americans lost some of their protective power, with vaccine efficacy among...
Novavax applies for FDA authorization of its protein-based COVID shot
By
Amy Novotney
Feb 02, 2022
Biotech firm Novavax disclosed Monday that it had submitted its long-awaited application to the U.S. Food and Drug Administration for an emergency use authorization for its COVID-19 vaccine in the United...
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...